The Therapeutic Goods Administration (TGA) approved the inclusion of the Koning Breast CT System, CBCT 1000, under ARTG No. 531059 on September 8, 2026. With the device now included in the ARTG, commercial supply in Australia may begin in accordance with applicable regulatory requirements and the conditions of the ARTG inclusion.
“This is an important milestone for Koning and for our continued global expansion,” said David Georges, President of Koning. “We are grateful to everyone who worked tirelessly to bring this technology to Australia, and we look forward to supporting providers as they introduce a new approach to dedicated breast imaging for their patients.”